From the Journals

HCV, HBV, and HIV associated with autoimmune kidney diseases


 

FROM RHEUMATIC DISEASE CLINICS

Chronic viral infection can be associated with a variety of autoimmune kidney diseases, according to a review published in Rheumatic Disease Clinics.

London_England/Thinkstock

In particular, hepatitis C virus (HCV) infection can cause several kidney disorders. These include cryoglobulinemic glomerulonephritis, membranous nephropathy, fibrillary glomerulopathy, immunotactoid glomerulopathy, and IgA nephropathy, wrote Joshua D. Long and his colleagues at Massachusetts General Hospital, Boston.

Similarly, hepatitis B virus (HBV) infection was found to be associated with both membranous nephropathy and polyarteritis nodosa, and human immunodeficiency virus (HIV) infection can cause HIV-associated nephropathy and HIV-associated immune complex diseases, which affect the kidneys.

In their detailed review, the authors discussed the various causal mechanisms and clinical presentations of each of these various autoimmune kidney diseases caused by HCV, HBV, and HIV, along with current treatment modalities.

“Control of the kidney disease relies primarily on treatment of viremia with antiviral agents; however, immunosuppression also may be needed in severe cases,” said the reviewers. However, “more clinical trials are needed to determine first-line therapies for patients who develop autoimmune kidney diseases in the context of chronic viral infections and to define when adjunctive immunosuppressive therapy is warranted,” they concluded.

One of the authors reported grant support and acting as a consultant for various pharmaceutical companies.

mlesney@mdedge.com

SOURCE: Long JD et al. Rheum Dis Clin N Am 2018;44:675-98.

Recommended Reading

Genetic composition of HCV changes with HIV coinfection
Federal Practitioner
Barriers loom for HCV care in young people who inject drugs
Federal Practitioner
Witnessed overdose, HCV infection associated with greater opioid overdose risk
Federal Practitioner
Model finds spontaneous HCV clearance higher than previous estimates
Federal Practitioner
HIV, HBV, and HCV Increase Risks After Joint Replacement
Federal Practitioner
What’s The Impact of Occult HBV in Chronic HCV?
Federal Practitioner
Disappointing Results From a Cetuximab Study
Federal Practitioner
Myeloperoxidase elevated in HCV-related liver cancer
Federal Practitioner
Automated algorithm improves HIV/HCV screening in the ED
Federal Practitioner
HCV adapts to HIV coinfection
Federal Practitioner